Literature DB >> 19676147

Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease.

Maria Mesquita1, Anne Demulder, Nasroolla Damry, Christian Mélot, Eric Wittersheim, Dominique Willems, Max Dratwa, Pierre Bergmann.   

Abstract

BACKGROUND: Cardiovascular disease is the major cause of morbidity and mortality in chronic kidney disease (CKD) and early biomarkers are required which can predict disease and death in such patients. The aim of our study was to investigate if osteoprotegerin (OPG) could be a predictor of coronary artery calcification (CAC) and mortality in CKD.
METHODS: A total of 77 outpatients (32 with pre-dialysis CKD and 45 undergoing hemodialysis) were followed-up during 2 years. Measurements of CAC were performed using Siemens Multidetector CT software and calcium scores were measured according to the Agatston method.
RESULTS: OPG was an independent predictor of the Agatston score for CAC and correlated with the degree of CAC in pre-dialysis patients. A two-sample t-test characterized survivors as having a better glomerular filtration rate, lower Agatston scores, and lower serum levels of OPG. Kaplan-Meier survival curves separated survivors from non-survivors at plasma OPG cut-off levels of <3.1 ng/mL. A multivariable logistic regression analysis showed that OPG was an independent predictor of mortality from all causes in CKD patients.
CONCLUSIONS: OPG predicted mortality in CKD patients and could be a valuable biomarker in early detection of CAC in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19676147     DOI: 10.1515/CCLM.2009.075

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

Review 1.  Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors:  Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

Review 2.  A current understanding of vascular calcification in CKD.

Authors:  Neil J Paloian; Cecilia M Giachelli
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

3.  Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.

Authors:  A Nakashima; J J Carrero; A R Qureshi; T Hirai; N Takasugi; T Ueno; Y Taniguchi; B Lindholm; N Yorioka
Journal:  Osteoporos Int       Date:  2010-09-02       Impact factor: 4.507

4.  Significant Association between OPG/TNFRSF11B Variant and Common Complex Ischemic Stroke.

Authors:  Xin Xiong; Duraid Hamied Naji; Binbin Wang; Yuanyuan Zhao; Junhan Wang; Dan Wang; Yuting Zhang; Sisi Li; Shanshan Chen; Yufeng Huang; Qin Yang; Xiaojing Wang; Dan Yin; Xin Tu; Qiuyun Chen; Xu Ma; Chengqi Xu; Qing K Wang
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-02-28       Impact factor: 2.136

Review 5.  Phosphate Is a Cardiovascular Toxin.

Authors:  Maren Leifheit-Nestler; Isabel Vogt; Dieter Haffner; Beatrice Richter
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease.

Authors:  Paul F Stahls; Daniel J Lightell; Stephanie C Moss; Corey K Goldman; T Cooper Woods
Journal:  J Cardiovasc Transl Res       Date:  2012-12-04       Impact factor: 4.132

7.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

8.  Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.

Authors:  M M Nascimento; S Y Hayashi; M C Riella; B Lindholm
Journal:  Braz J Med Biol Res       Date:  2014-08-22       Impact factor: 2.590

Review 9.  Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.

Authors:  Jin Sug Kim; Hyeon Seok Hwang
Journal:  Korean Circ J       Date:  2021-12       Impact factor: 3.243

10.  Association of sclerostin with cardiovascular events and mortality in dialysis patients.

Authors:  Yun Zou; Min Yang; Jiao Wang; Li Cui; Zhenxing Jiang; Jiule Ding; Min Li; Hua Zhou
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.